Blog Posts - Drug Safety Alerts

Emerging Drug Safety Issue: Possible Increased Risk Of Pancreatic Cancer With Byetta, Januvia, And Victoza -- Little Is Known About Long-Term Effects

As "Pancreatitis Is On The Pathway Toward Pancreatic Cancer", Medical Studies Needed To Determine If GLP-1 Diabetes Medications Linked To Cancers Or Malignancies Involving Pancreas (Posted by Tom Lamb at We last wrote a...
by Drug Injury Watch on Mar 18, 2013

Kidney Dialysis Anemia Drug Recall: Omontys: Hypersensitivity / Allergic Reactions And Anaphylaxis; Serious Side Effects With Some Being Fatal

Omontys: Deaths During Initial Injection Within 30 Minutes During Treatment Of Anemia Due To Chronic Kidney Disease In Hemodialysis Patients (Posted by Tom Lamb at The Omontys (peginesatide) injection was approved in March 2012 t...
by Drug Injury Watch on Feb 25, 2013

December 2012 Pradaxa Label Change: Contraindication: Use By Mechanical Heart Valves Patients

A Look At The Events And The Evidence Leading Up To This Latest FDA Action Concerning The Safety Of Pradaxa (Posted by Tom Lamb at We set the stage with this December 19, 2012 drug company press release, "Boehringer Ingelhei...
by Drug Injury Watch on Dec 26, 2012

Multiple Sclerosis (MS) Medication Gilenya: Timeline Of Actions Taken In US, Canada, And Europe

Increasing Safety Concerns About Novartis Drug Gilenya Are Primarily Cardiovascular Side Effects And Unexplained Death (Posted by Tom Lamb at In August 2012 Health Canada issued the latest drug safety alert concerning Gilenya (fi...
by Drug Injury Watch on Aug 27, 2012

New 2012 Medical Study Shows NuvaRing Doubles The Risk Of Stroke And Heart Attack, And The Degree Of Risk Increases With Age

NuvaRing Contraceptive Vaginal Ring Associated With Blood Clots In Arteries That Might Cause Thrombotic Strokes And Myocardial Infarctions (MI) (Posted by Tom Lamb at A Danish study published in June 2012 by The New England of Me...
by Drug Injury Watch on Aug 7, 2012

Pradaxa: Excess Number Of Severe Bleeding Events In Certain Patient Populations And Settings

At Increased Risk Are Patients Who Are Older, Have Altered Renal Clearance, Or Undergoing Atrial Fibrillation (AF) Ablation (Posted by Tom Lamb at We first reported about Pradaxa (dabigatran) back in October 2011 in this article...
by Drug Injury Watch on Feb 10, 2012

Pneumonia Trial Of Janssen / J&J Antibiotic Doribax Was Stopped In May 2011 -- We Learn From The FDA In January 2012

"Significant Safety Concern": Higher Death Rate For Doribax In Ventilator-Associated Pneumonia When Compared To Patients Receiving Imipenem Therapy (Posted by Tom Lamb at ________________________________________________...
by Drug Injury Watch on Jan 30, 2012

Trending Topics